These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 3557732

  • 1. Serum levels of free non-protein bound clofibrinic acid after single dosing to patients with impaired renal function of various degrees--a multicenter study.
    Merk W, Graben N, Hartmann H, Nikolaus C, Schlierf G, Schwandt P.
    Int J Clin Pharmacol Ther Toxicol; 1987 Feb; 25(2):59-62. PubMed ID: 3557732
    [Abstract] [Full Text] [Related]

  • 2. The use of clofibrate in patients with renal insufficiency.
    Viikari J, Anttila M, Kasanen A.
    Int J Clin Pharmacol Ther Toxicol; 1983 Feb; 21(2):77-80. PubMed ID: 6840929
    [Abstract] [Full Text] [Related]

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 4. Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism.
    Rostaing L, Moreau-Gaudry X, Baron E, Cisterne JM, Monroziès-Bernadet P, Durand D.
    Clin Nephrol; 1997 Apr; 47(4):248-55. PubMed ID: 9128792
    [Abstract] [Full Text] [Related]

  • 5. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP, Leung KT, Tong MK, Kwan TH.
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [Abstract] [Full Text] [Related]

  • 6. Serum protein binding of phenytoin, diazepam and propranolol in chronic renal diseases.
    Tiula E, Tallgren LG, Neuvonen PJ.
    Int J Clin Pharmacol Ther Toxicol; 1987 Oct; 25(10):545-52. PubMed ID: 3429058
    [Abstract] [Full Text] [Related]

  • 7. [Study of the binding characteristics of chlorophenoxyisobutyric acid to serum proteins in chronically uremic patients : influence of dialysis and heparine (author's transl)].
    Lacour B, Di Giulio S, Nicolaï A, Drüeke T, Debray M, Boulu RG.
    Nephrologie; 1982 Oct; 3(1):19-22. PubMed ID: 7088259
    [Abstract] [Full Text] [Related]

  • 8. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [Abstract] [Full Text] [Related]

  • 9. Saliva and plasma levels and plasma protein binding of clofibrinic acid in uremic patients.
    Bjornsson TD, Meffin PJ, Peters FA, Blaschke TF.
    Clin Pharmacol Ther; 1980 Feb; 27(2):230-5. PubMed ID: 7353345
    [Abstract] [Full Text] [Related]

  • 10. The effect of a keto acid supplement on the course of chronic renal failure and nutritional parameters in predialysis patients and patients on regular hemodialysis therapy: the Hungarian Ketosteril Cohort Study.
    Zakar G, Hungarian Ketosteril Cohort Study.
    Wien Klin Wochenschr; 2001 Sep 17; 113(17-18):688-94. PubMed ID: 11603104
    [Abstract] [Full Text] [Related]

  • 11. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
    Iglesias P, Díez JJ, Fernández-Reyes MJ, Méndez J, Bajo MA, Aguilera A, Selgas R.
    Clin Endocrinol (Oxf); 2004 Jun 17; 60(6):741-9. PubMed ID: 15163339
    [Abstract] [Full Text] [Related]

  • 12. Urea kinetic modelling in two groups of patients on continuous ambulatory peritoneal dialysis.
    Barton EN, Morgan AG, Burden RP.
    West Indian Med J; 1997 Jun 17; 46(2):57-9. PubMed ID: 9260536
    [Abstract] [Full Text] [Related]

  • 13. Parathyroid function after successful renal transplantation.
    Botha JF, Botha JR.
    S Afr J Surg; 1997 Aug 17; 35(3):113-6. PubMed ID: 9429326
    [Abstract] [Full Text] [Related]

  • 14. Characteristics of serum protein binding of felodipine.
    Valle M, Esteban M, Rodríguez-Sasiaín JM, Calvo R, Aguirre C.
    Res Commun Mol Pathol Pharmacol; 1996 Oct 17; 94(1):73-88. PubMed ID: 8948016
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of anakinra in subjects with different levels of renal function.
    Yang BB, Baughman S, Sullivan JT.
    Clin Pharmacol Ther; 2003 Jul 17; 74(1):85-94. PubMed ID: 12844139
    [Abstract] [Full Text] [Related]

  • 16. The effect of renal function on serum levels of CA 125.
    Menzin AW, Kobrin S, Pollak E, Goodman DB, Rubin SC.
    Gynecol Oncol; 1995 Sep 17; 58(3):375-7. PubMed ID: 7672704
    [Abstract] [Full Text] [Related]

  • 17. Interactions of serum albumin, valproic acid and carbamazepine with the pharmacokinetics of phenytoin in cancer patients.
    Joerger M, Huitema AD, Boogerd W, van der Sande JJ, Schellens JH, Beijnen JH.
    Basic Clin Pharmacol Toxicol; 2006 Aug 17; 99(2):133-40. PubMed ID: 16918714
    [Abstract] [Full Text] [Related]

  • 18. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Sep 17; 423():1-336. PubMed ID: 12616288
    [Abstract] [Full Text] [Related]

  • 19. Effects of the oral adsorbent AST-120 on tryptophan metabolism in uremic patients.
    Tsubakihara Y, Takabatake Y, Oka K, Shoji T, Togawa M, Okada N, Takahito I, Imai E.
    Am J Kidney Dis; 2003 Mar 17; 41(3 Suppl 1):S38-41. PubMed ID: 12612950
    [Abstract] [Full Text] [Related]

  • 20. The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients.
    Caspi D, Lubart E, Graff E, Habot B, Yaron M, Segal R.
    Arthritis Rheum; 2000 Jan 17; 43(1):103-8. PubMed ID: 10643705
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.